Home › Lymphedema › NCT07855627
Prediction Of Lymphedema In Patients With Inflammatory BreastCancer Using Preoperative Bioimpedance Measurements
RecruitingObservational study
Who can join
Ages 18 and older · Women
Full eligibility criteria
Eligibility Criteria All women≥18 years old with newly diagnosed inflammatory breast cancer without prior breast/axillary surgery who are eligible for standard of care (NST, MRM, and radiation therapy). Exclusion Criteria Prior breast/axillary surgery. Participants with pacemakers or other implanted electronic medical devices. Participants with implanted metallic material. All vulnerable populations, including children, pregnant women, and cognitively impaired adult
About the study
To find out whether the BIA test can help identify participants with IBC who are at risk for developing lymphedema.
What is being tested
- Neoadjuvant therapy (drug)
Sponsor: M.D. Anderson Cancer Center · Participants: 150 · Started: Sep 16, 2026
Contact the study team
- Anthony Lucci, MD · Phone: 713-563-1871
Official record on ClinicalTrials.gov — NCT07855627
Locations in the U.S.
| Texas | UT MD Anderson Cancer Center, Houston |
Conditions
From ClinicalTrials.gov, data retrieved Oct 3, 2026. Each study sets its own eligibility; the study team decides who can join.